Geneva Advisors’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$834K Buy
16,140
+617
+4% +$31.8K 0.01% 399
2017
Q1
$832K Sell
15,523
-4,979
-24% -$282K 0.01% 391
2016
Q4
$1.27M Buy
20,502
+2,555
+14% +$141K 0.02% 282
2016
Q3
$918K Buy
17,947
+580
+3% +$27.2K 0.02% 342
2016
Q2
$670K Buy
17,367
+6,213
+56% +$230K 0.01% 384
2016
Q1
$363K Buy
+11,154
New +$327K 0.01% 505

Other funds holding LDL

Geneva Advisors's LDL Position: Q2 2017 in Review

Geneva Advisors increased its Lydall, Inc. (LDL) stake by 4% in Q2 2017, buying an estimated $31.8K and bringing the position to 16,140 shares worth $834K. The position accounts for 0.01% of the portfolio, ranked #399.

Geneva Advisors first reported a position in LDL in Q1 2016 and has held it in 6 quarters since. The position peaked at $1.27M in Q4 2016. 147 funds tracked by Wall St. Rank hold LDL as of Q2 2017.

  • Geneva Advisors held 16,140 shares of Lydall, Inc. worth $834K as of Q2 2017.
  • Geneva Advisors bought 617 Lydall, Inc. shares in Q2 2017, an estimated $31.8K.
  • Lydall, Inc. made up 0.01% of Geneva Advisors's portfolio in Q2 2017, its #399 holding.
  • Geneva Advisors first reported a position in Lydall, Inc. in Q1 2016 and has held it in 6 quarters since.
  • Geneva Advisors's Lydall, Inc. position peaked at $1.27M in Q4 2016.
  • 147 funds tracked by Wall St. Rank held Lydall, Inc. as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.